Enhancing the QUAlity and Transparency Of health Research
Use your browser's Back button to return to your search results
|Reporting guideline provided for?
(i.e. exactly what the authors state in the paper)
|Reporting clinically relevant and more informative adverse event information in clinical trial publications.|
|Full bibliographic reference||Lineberry N, Berlin JA, Mansi B, Glasser S, Berkwits M, Klem C, Bhattacharya A, Citrome L, Enck R, Fletcher J, Haller D, Chen TT, Laine C. Recommendations to improve adverse event reporting in clinical trial publications: a joint pharmaceutical industry/journal editor perspective.
|Study design||Clinical trials, Experimental studies|
|Applies to the whole report or to individual sections of the report?||Harms/adverse effects/safety data|
|Record last updated on||October 11, 2016|
Some reporting guidelines are also available in languages other than English. Find out more in our Translations section.